UBS AM
OPTR

UBS AM’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

UBS AM’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,198
Closed -$229K – 2617
2013
Q3 		$229K Sell
18,198
-642,757
-97% -$8.52M ﹤0.01% 2260
2013
Q2 		$9.56M Buy
+660,955
New +$9.62M 0.01% 782

UBS AM's OPTR Position: Q4 2013 in Review

UBS AM sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 18,198 shares — an estimated $229K sold.

UBS AM first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $9.56M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • UBS AM reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • UBS AM sold 18,198 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $229K.
  • UBS AM first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • UBS AM's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $9.56M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.